Cargando…

Recombinant Lipidated HPV E7 Induces a Th-1-Biased Immune Response and Protective Immunity against Cervical Cancer in a Mouse Model

The E7 oncoprotein of human papillomavirus (HPV) is an ideal target for developing immunotherapeutic strategies against HPV-associated tumors. However, because protein-based immunogens alone are poor elicitors of the cytotoxic T-lymphocyte (CTL) responses, they have been difficult to exploit for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chiung-Yi, Chen, Jeremy J. W., Shen, Kuan-Yin, Chang, Li-Sheng, Yeh, Yi-Chen, Chen, I-Hua, Chong, Pele, Liu, Shih-Jen, Leng, Chih-Hsiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399806/ https://www.ncbi.nlm.nih.gov/pubmed/22815882 http://dx.doi.org/10.1371/journal.pone.0040970

Ejemplares similares

Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy
por: Huang, Chung-Hsiung, et al.
Publicado: (2016)

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2018)

Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
por: Chang, Li-Sheng, et al.
Publicado: (2014)

A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses
por: Chiang, Chen-Yi, et al.
Publicado: (2011)

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
por: Chiang, Chen-Yi, et al.
Publicado: (2016)

A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy
por: Song, Ying-Chyi, et al.
Publicado: (2014)

Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses
por: Chiang, Chen-Yi, et al.
Publicado: (2012)

Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in Mice
por: Huang, Ming-Hsi, et al.
Publicado: (2010)

Recombinant lipoprotein-based vaccine candidates against C. difficile infections
por: Huang, Jui-Hsin, et al.
Publicado: (2015)

Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide
por: Shen, Kuan-Yin, et al.
Publicado: (2014)

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
por: Liu, Shih-Jen, et al.
Publicado: (2006)

Lipidated Dengue-2 Envelope Protein Domain III Independently Stimulates Long-Lasting Neutralizing Antibodies and Reduces the Risk of Antibody-Dependent Enhancement
por: Chiang, Chen-Yi, et al.
Publicado: (2013)

Delivery of Antigen to CD8(+) Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2019)

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population
por: Wu, Chiao-Chieh, et al.
Publicado: (2016)

Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity
por: Liao, Hung-Chun, et al.
Publicado: (2022)

Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity
por: Lin, Kuo-Hsing, et al.
Publicado: (2016)

Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples?
por: Shih, Yu-Hsiang, et al.
Publicado: (2023)

Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types
por: Hsieh, Ming-Shu, et al.
Publicado: (2023)

Identification of synthetic vaccine candidates against SARS CoV infection
por: Lien, Shu-Pei, et al.
Publicado: (2007)

CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses
por: Yeh, Da-Wei, et al.
Publicado: (2017)

Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies
por: Shen, Kuan‐Yin, et al.
Publicado: (2022)

Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
por: Gan, Qiyu, et al.
Publicado: (2023)

A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge
por: Chiu, Fang-Feng, et al.
Publicado: (2023)

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
por: Yi, Baozhu, et al.
Publicado: (2022)

The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia
por: Mu, Lin, et al.
Publicado: (2020)

Delivery of Human EV71 Receptors by Adeno-Associated Virus Increases EV71 Infection-Induced Local Inflammation in Adult Mice
por: Hsiao, Hung-Bo, et al.
Publicado: (2014)

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
por: Pan, Yi-Ru, et al.
Publicado: (2020)

Potential role of naturally acquired immunity against HPV in the control of HPV related diseases
por: Tian, Tian, et al.
Publicado: (2021)

Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
por: Hsu, Yaw-Wen, et al.
Publicado: (2017)

Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles
por: Lin, Shih-Chang, et al.
Publicado: (2012)

Common Microbial Genital Infections and Their Impact on the Innate Immune Response to HPV in Cervical Cells
por: Fracella, Matteo, et al.
Publicado: (2022)

The Immunodominance Change and Protection of CD4(+) T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice
por: Chen, Hsin-Wei, et al.
Publicado: (2015)

HPV - immune response to infection and vaccination
por: Stanley, Margaret
Publicado: (2010)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Innate immunity and HPV: friends or foes
por: Nunes, Rafaella Almeida Lima, et al.
Publicado: (2018)

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)
por: Lai, Szu-Chia, et al.
Publicado: (2005)

Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
por: Wu, Chiao-En, et al.
Publicado: (2020)

Diagnostic Management of Oncogenic HPV Cervical Infections: The Field Experience in Wuxi, China
por: Liu, Yang, et al.
Publicado: (2022)

Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
por: Łaniewski, Paweł, et al.
Publicado: (2018)

Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians
por: Santos, Ana Carolina da Silva, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g1r9tpjrk4uklntmpq7nrn6vis